tirzepatide short term use for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN Short-Term Tirzepatide Use for Weight

The proportion of participants experiencing gastrointestinal adverse events was similar between treatment groups (IcoSema 31.4%

Most cases stemmed from unintentional dosing or therapeutic errors rather than deliberate misuse, but the researchers found the massive increase jarring nonetheless

Semaglutide significantly reduced LVH, improve mitophagy, and down-regulated NLRP3 inflammatory signal pathway in TAC rats

The global glucagon-like peptide-1 receptor agonist (GLP-1) market has experienced significant growth and is projected to expand further

100% online, no insurance needed

The molecular mechanism by which GLP-1 protects MG-induced beta cell apoptosis remains unclear